Herpes Simplex Virus Treatment Market - Next-Generation Antivirals and Drug Resistance
Market Overview The HSV treatment market is experiencing antiviral advancement emphasis where next-generation agents, resistance management, and drug development drive therapeutic options and efficacy improvement. The HSV treatment market is projected to exceed USD 8.2 billion through 2030, with antiviral emphasis driven by resistance concerns, efficacy focus, and treatment innovation. Advanced...
0 Σχόλια 0 Μοιράστηκε 41 Views 0 Προεπισκόπηση